• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心血管疾病的全球风险与目标]

[Global risk and objectives in cardiovascular diseases].

作者信息

Güleç Sadi

机构信息

Department of Cardiology, Medicine Faculty of Ankara University, Ankara, Turkey.

出版信息

Turk Kardiyol Dern Ars. 2009 Mar;37 Suppl 2:1-10.

PMID:19404044
Abstract

The management of diseases arising from a single cause is straightforward. However, with regard to the clinical manifestations of atherosclerotic disease (coronary heart disease, stroke, peripheral vascular disease, and aneurysms) the situation is more complex, since atherosclerosis represents the product of multiple interacting risk factors. The modern approach to managing cardiovascular risks is to reduce an individual's total or global risk, rather than grading risk by individual risk factors alone. Recent guidelines stress the need for total risk estimation and recommend the use of risk charts like Framingham or SCORE before treating risk factors like dyslipidemia. One should keep in mind that treatment should be directed to those at greatest risk and management decisions based on a single risk factor may be misleading. For instance, a male smoker with a cholesterol level of 200 mg/dl and systolic blood pressure of 160 mmHg can be at four times higher risk than a female non-smoker with a cholesterol level of 300 mg/dl and systolic blood pressure of 120 mmHg, indicating a higher global risk and priority for the treatment of dyslipidemia. If risk assessment is based on the cholesterol alone, then this woman would have a higher priority than the man due to the higher cholesterol level. In this review, global risk management strategies will be discussed in detail.

摘要

由单一病因引起的疾病管理较为简单直接。然而,就动脉粥样硬化性疾病(冠心病、中风、外周血管疾病和动脉瘤)的临床表现而言,情况更为复杂,因为动脉粥样硬化是多种相互作用的风险因素共同作用的结果。现代管理心血管风险的方法是降低个体的总体或综合风险,而不是仅依据单个风险因素来分级风险。近期的指南强调了进行总体风险评估的必要性,并建议在治疗血脂异常等风险因素之前,使用如弗明汉或SCORE等风险图表。应当牢记,治疗应针对风险最高的人群,基于单一风险因素做出的管理决策可能会产生误导。例如,一名胆固醇水平为200毫克/分升且收缩压为160毫米汞柱的男性吸烟者,其风险可能比一名胆固醇水平为300毫克/分升且收缩压为120毫米汞柱的女性非吸烟者高出四倍,这表明前者具有更高的总体风险以及治疗血脂异常的更高优先级。如果仅基于胆固醇进行风险评估,那么由于胆固醇水平较高,这名女性的优先级会高于该男性。在本综述中,将详细讨论总体风险管理策略。

相似文献

1
[Global risk and objectives in cardiovascular diseases].[心血管疾病的全球风险与目标]
Turk Kardiyol Dern Ars. 2009 Mar;37 Suppl 2:1-10.
2
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.肾移植后第一年,早期停用皮质类固醇激素情况下的全球心血管风险会逐渐降低。
Transplant Proc. 2005 Mar;37(2):812-3. doi: 10.1016/j.transproceed.2005.01.060.
3
Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.1978年至2001年撒丁岛心血管疾病的风险因素:与意大利大陆的比较研究
Eur J Intern Med. 2009 Jul;20(4):373-7. doi: 10.1016/j.ejim.2008.10.007. Epub 2008 Dec 21.
4
The effect of blood pressure and cholesterol variability on the precision of Framingham cardiovascular risk estimation: a simulation study.血压和胆固醇变异性对弗雷明汉心血管风险评估精度的影响:一项模拟研究。
J Hum Hypertens. 2010 Oct;24(10):631-8. doi: 10.1038/jhh.2009.114. Epub 2010 Jan 7.
5
Total cardiovascular risk estimation in Romania. Data from the SEPHAR study.罗马尼亚的总体心血管风险评估。来自SEPHAR研究的数据。
Rom J Intern Med. 2008;46(1):29-37.
6
Goal attainment for multiple cardiovascular risk factors in community-based clinical practice (a Canadian experience).社区临床实践中多种心血管危险因素的目标达成情况(加拿大的经验)
J Eval Clin Pract. 2009 Feb;15(1):212-6. doi: 10.1111/j.1365-2753.2008.01002.x.
7
[Changes in the panorama of risk factors in heart and vascular diseases].[心脏与血管疾病危险因素全景的变化]
Nord Med. 1994;109(2):50-3.
8
[Cardiovascular risk factors -- from the mathematical formula to clinical practice].[心血管危险因素——从数学公式到临床实践]
Acta Med Port. 2002 Jul-Aug;15(4):277-80.
9
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.评估心血管风险的现有评分的价值与局限性:临床医生综述
J Am Coll Cardiol. 2009 Sep 29;54(14):1209-27. doi: 10.1016/j.jacc.2009.07.020.
10
[Assessment of the absolute global cardiovascular risk: comparison between the risk chart and the individual score of the CUORE Project].[全球心血管绝对风险评估:风险图表与CUORE项目个体评分的比较]
G Ital Cardiol (Rome). 2006 May;7(5):359-64.

引用本文的文献

1
Framingham risk score and severity of coronary artery disease.弗雷明汉风险评分与冠状动脉疾病的严重程度
Herz. 2014 Aug;39(5):638-43. doi: 10.1007/s00059-013-3881-4. Epub 2013 Jul 21.